Compare · SAP vs SNCE
SAP vs SNCE
Side-by-side comparison of SAP SE (SAP) and Science 37 Holdings Inc. (SNCE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both SAP and SNCE operate in Computer Software: Prepackaged Software (Technology), so they compete in similar markets.
- SAP is the larger of the two at $196.56B, about 213.4x SNCE ($921.1M).
- SAP has hit the wire 3 times in the past 4 weeks while SNCE has been quiet.
- SAP has more recent analyst coverage (25 ratings vs 5 for SNCE).
- Company
- SAP SE
- Science 37 Holdings Inc.
- Price
- $160.09+9.43%
- $5.75+0.17%
- Market cap
- $196.56B
- $921.1M
- 1M return
- +4.80%
- -
- 1Y return
- -44.40%
- -
- Industry
- Computer Software: Prepackaged Software
- Computer Software: Prepackaged Software
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- News (4w)
- 3
- 0
- Recent ratings
- 25
- 5
SAP SE
SAP SE operates as an enterprise application software company worldwide. The company operates through four segments: Applications, Technology & Support; Concur; Qualtrics; and Services. It offers SAP S/4HANA, an enterprise resource planning suite for intelligent technologies; SAP Integrated Business Planning for Supply Chain, a cloud-based solution that delivers real-time supply chain planning capabilities; SAP Intelligent Asset Management, a solution that helps to define, plan, and monitor service and maintenance strategy; SAP SuccessFactors Human Experience Management Suite, a cloud software that helps to develop, manage, and engage people; SAP Ariba, a digital business-to-business marketplace; SAP Concur, a travel and expense management software; and SAP Fieldglass, a cloud application for services procurement and contingent workforce management. The company also provides SAP solutions for enterprise information management that offers capabilities to understand, integrate, cleanse, manage, associate, and archive data; SAP HANA and SAP HANA Cloud, which enables businesses to process and analyze live data; SAP Analytics Cloud, a cloud analytics solution; SAP BusinessObjects Business Intelligence, a suite of flexible and scalable self-service BI tools; SAP Data Warehouse Cloud, a cloud data warehouse solution for business and IT users; and SAP BW/4HANA, an on-premise data warehouse solution. In addition, it offers SAP Integration Suite that help customers with holistic integration, and API-based and event-based integrations; SAP Extension Suite that provides ready-to-use services to accelerate and develop application extensions; SAP Internet of Things, a cloud solution that generates business outcomes; and SAP Intelligent Robotic Process Automation, a software robot to mimic human actions and responses. SAP SE was founded in 1972 and is headquartered in Walldorf, Germany.
Latest SAP
- BMO Capital Markets reiterated coverage on SAP SE with a new price target
- SAP Quarterly Statement Q2 2026
- SAP Celebrates America's 250th with Investment in the Next Generation
- INFRONEER Teams with Accenture to Build New Financial Data and Insights Platform to Advance its Group Management Capabilities in Just Three Months
- SEC Form 11-K filed by SAP SE
- Answerthink® Receives 2026 North America SAP® Partner Award for SAP Business Data Cloud Success
- SAP Unveils the Autonomous Enterprise
- SAP and Cyberwave Deploy Fully Autonomous AI-Powered Robots in Live SAP Logistics Warehouse
- SEC Form 6-K filed by SAP SE
- SAP Executives to Participate in Upcoming Investor Events
Latest SNCE
- Science 37 Completes Third FDA Inspection, Validating Quality of its Direct-to-Patient Site in Pivotal Phase 3 Rare Disease Trial
- Science 37 and Catalent Announce Partnership Enabling Universal Access to Clinical Research
- Science 37 Completes Second FDA Inspection as Enrollment Leader in Phase 3 Asthma Trial
- Science 37 Appoints Tyler Van Horn as CEO to Lead Next Era of Patient-Access Innovation
- Science 37 Nearly Doubles U.S. Enrollment for GSK Phase 3 Rare Disease Trial
- Science 37 Unveils New Corporate Headquarters in Research Triangle Park, NC
- Science 37 Enrolls 42% of Trial Cohort in 8 Weeks
- Science 37 Quickly Impacts Performance in Under-Enrolling Clinical Trials
- Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial
- Science 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and Compliance